Invesco Ltd. Has $147.02 Million Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Invesco Ltd. boosted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 14.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 793,080 shares of the company's stock after buying an additional 99,030 shares during the period. Invesco Ltd. owned approximately 2.65% of Inspire Medical Systems worth $147,021,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. MML Investors Services LLC raised its stake in Inspire Medical Systems by 8.6% during the 3rd quarter. MML Investors Services LLC now owns 7,874 shares of the company's stock valued at $1,662,000 after purchasing an additional 625 shares during the last quarter. M&T Bank Corp lifted its stake in shares of Inspire Medical Systems by 53.1% in the third quarter. M&T Bank Corp now owns 3,228 shares of the company's stock valued at $681,000 after buying an additional 1,120 shares during the period. Geode Capital Management LLC grew its position in Inspire Medical Systems by 0.7% during the third quarter. Geode Capital Management LLC now owns 483,654 shares of the company's stock worth $102,102,000 after buying an additional 3,128 shares in the last quarter. Tidal Investments LLC bought a new position in Inspire Medical Systems during the third quarter valued at about $320,000. Finally, Synovus Financial Corp raised its holdings in Inspire Medical Systems by 7.5% in the 3rd quarter. Synovus Financial Corp now owns 3,502 shares of the company's stock valued at $739,000 after acquiring an additional 244 shares in the last quarter. 94.91% of the stock is owned by institutional investors.

Remove Ads

Inspire Medical Systems Stock Down 2.1 %

NYSE INSP traded down $3.11 during trading hours on Tuesday, hitting $146.59. The company's stock had a trading volume of 273,216 shares, compared to its average volume of 591,130. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The firm has a market capitalization of $4.36 billion, a P/E ratio of 84.73, a PEG ratio of 2.86 and a beta of 1.39. The stock has a fifty day moving average of $168.13 and a 200 day moving average of $184.49.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on INSP. Wells Fargo & Company cut their target price on Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a research note on Tuesday, February 11th. Piper Sandler decreased their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research report on Monday, February 10th. Morgan Stanley lowered their price objective on Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating on the stock in a research note on Tuesday, February 11th. Stifel Nicolaus decreased their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating on the stock in a research note on Tuesday, January 21st. Finally, KeyCorp reaffirmed an "overweight" rating and set a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Inspire Medical Systems has a consensus rating of "Moderate Buy" and an average target price of $222.20.

Insider Activity

In related news, CTO John Rondoni sold 583 shares of the firm's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now owns 10,424 shares of the company's stock, valued at approximately $1,777,187.76. This trade represents a 5.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Randy Ban sold 25,584 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now directly owns 7,259 shares of the company's stock, valued at approximately $1,332,026.50. The trade was a 77.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.10% of the stock is currently owned by company insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.